Abstract:Objective To evaluate the efficacy and safety of different courses of luliconazole 1％ cream in the treatment of tinea pedis.Methods A randomized,double-blind,multicenter controlled trial was conducted.According to a stratified randomization protocol,420 patients positive for fungal elements on direct microscopy were equally and randomly divided into 3 groups:short-term group applying luliconazole 1％ cream once daily for 2 weeks followed by placebo once daily for the next 2 weeks,long-term group applying luliconazole 1％ cream once daily for 4 weeks,bifonazole group applying bifonazole 1％ cream once daily for 4 weeks.Efficacy was assessed in terms of mycological clearance and clinical response rates on week 2,3,4 and 6 after initiation of treatment.Statistical analysis was carried out by paired t test,analysis of variance,chi-square test and a nonparametric test.Results Finally,398 patients were eligible for the efficacy analysis.The clinical response rate in the bifonazole group,shortterm group and long-term group was 29.29％,31.43％ and 35.00％ respectively on week 2 after initiation of treatment (P ＞ 0.05),73.57％,78.57％ and 70.00％ respectively on week 3 (P ＞ 0.05),89.29％,91.43％ and 89.29％ respectively on week 4 (P ＞ 0.05),with the mycological clearance rate being 49.29％,58.57％ and 57.86％ respectively on week 2 (P ＞ 0.05),80.00％,87.86％ and 85.00％ respectively on week 4 (P ＞ 0.05).Significant differences were observed on week 2 after the end of treatment in mycological clearance rate (80.71％ in the bifonazole group vs.90.00％ in the short-term group vs.89.29％ in the long-term group,P ＜ 0.05),but not in clinical response rate (92.14％ in the bifonazole group vs.92.86％ in the short-term group vs.92.14％ in the longterm group,P ＞ 0.05).The incidence rate of local adverse reactions was 0.71％ in the bifonazole group,0 in the short-term group and 2.14％ in the long-term group.Conclusion Luliconazole 1％ cream is effective and well tolerated in the treatment of tinea pedis,with the efficacy of 2-week once-daily regimen equivalent to that of 4-week once-daily regimen.

A randomized, double-blind, controlled study with luliconazle cream (1％) versus terbinafine cream (1％) in patients with tinea cruris

Evaluation of efficacy and safety of 1％ luliconazole cream in the treatment of tinea corporis and tinea cruris

Evaluation of efficacy and safety of 1% luliconazole cream in the treatment of tinea pedis

Terbinafine versus itraconazole for treatment of dermatophyte onychomycosis: a meta-analysis

Clinical effect observation of itraconazole capsule combined with bifona-zole cream in the treatment of tinea cruris

Comparison of 2 Weeks Versus 4 Weeks of Luliconazole 1％ Cream for the Treatment of Tinea Pedis: a Randomized, Double-Blind, Multicenter, Controlled Trial

Double-blind Randomized Controlled Clinical Trial of Butenafine Hydrochloride 1% Cream in the Treatment of Tinea Corporis and Cruris and Tinea Pedis

Bifonazole -Co Cream in the Treatment of Tinea Cruris and Tinea Corporis:A Randomized Double-blind Vehicle-controlled Clinical Trial

Topical Treatment of All-Trans Retinoic Acid Cream Combined with Penciclovir Cream for Verruca Plana: A Multiple Centre,double-Blind and Control Study

Comparative Study of Topical Terbinafine 1% Cream versus Butenafine 1% Cream in the Treatment of Tinea Cruris

The Curative Effect Observation of Sertaconazole Nitrate Cream in the Treatment of Tinea Cruris

Randomized, Investigator-Masked, Controlled, Multicenter Clinical Trial of 0.25% Amorolfine Hydrochloride Cream in the Treatment of Tinea Corporis and Cruris and Tinea Pedis

Analysis on Curative Effects and Safety of 2% Liranaftate Ointment in Treating Tinea Pedis and Tinea Corporis & Cruris.

Comparative efficacy of 1% terbinafine hydrochloride cream and 1% ciclopirox olamine cream alone and in combination for the treatment of dermatophytosis

Evaluation of Efficacy and Safety of 2 % Sertaconazole Nitrate Cream in the Treatment of Tinea Corporis & Cruris and Tinea Pedis

Experience of using the 1,5% Tetranyl U cream in patients with tinea corporis and tinea cruris

Evaluation of efficacy and safety of flutrimazole cream 1% in the treatment of tinea pedis

Multicenter, Double-Blind, Randomized Controlled Sdudy on Sertaconazole 2% Cream and Miconazole 2% Cream in the Treatment of Tinea Pedis and Tinea Corporis and Cruris

Comparison of 1-Week Terbinafime Hydrochloride Cream, 1- and 4-Week Miconazole Nitrate Cream in the Treatment of Interdigital Tinea Pedis: a Multi-Center, Randomized and Double-Blind Study

Efficacy of 1% Clotrimazole Powder Monotherapy for Treating Tinea Cruris: A Comparative Randomized Study

Efficacy and Safety of 1 % Terbinafine Film-Forming Solution in Chinese Patients with Tinea Pedis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study